Literature DB >> 31020256

Coronary artery disease concomitant with immunoglobulin G4-related disease: a case report and literature review.

Toraaki Okuyama1, Toshikazu D Tanaka1, Tomohisa Nagoshi1, Michihiro Yoshimura1.   

Abstract

BACKGROUND: Immunoglobulin G4-related disease (IgG4-RD) is an autoimmune condition associated with high serum IgG4 levels which was first reported as autoimmune pancreatitis in 2001. Since then, many additional organs, such as bile duct, salivary gland, retroperitoneal organs, and liver, have been reported with high serum IgG4 levels in cases of IgG4-RD. However, evidence of the relationship between IgG4-RD and coronary artery disease (CAD) has been scare. Here, we report a case of CAD concomitant with IgG4-RD. CASE
SUMMARY: A 74-year-old man was referred to our hospital with a chief complaint of chest pain and was admitted. The patient was found to have had a myocardial infarction with ST-segment elevation and underwent an emergent percutaneous coronary intervention. Owing to a rapidly increased blood glucose level, computed tomography was performed and showed autoimmune pancreatitis. An elevated serum level of IgG4 led to a diagnosis of IgG4-RD involving acute coronary syndrome (ACS). DISCUSSION: Cardiac involvement in IgG4-RD has been reported; however, cases of ACS concomitant with IgG4-RD are rare. Our report suggests that CAD, specifically ACS, can coexist in patients with IgG4-RD. Therefore, cases of concomitant CAD and IgG4-RD should be accurately diagnosed and evidence should be collected to elucidate the mechanism and characteristics of this condition.

Entities:  

Keywords:  Case report; Coronary artery disease; Coronary computed tomography angiography; Immunoglobulin G4-related disease

Year:  2019        PMID: 31020256      PMCID: PMC6439393          DOI: 10.1093/ehjcr/ytz013

Source DB:  PubMed          Journal:  Eur Heart J Case Rep        ISSN: 2514-2119


Learning points

Immunoglobulin G4-related disease (IgG4-RD) is a relatively new disease concept that was first reported as a type of autoimmune pancreatitis in 2001. Most reported cases of IgG4-RD with cardiovascular involvement have included abdominal aortic disease, with coronary artery disease (CAD) being rare. We describe a case of CAD, specifically acute coronary syndrome, coexisting with IgG4-RD. Therefore, cases of concomitant CAD and IgG4-RD should be accurately diagnosed and evidence should be collected to elucidate the mechanism and characteristics of this condition.

Introduction

Immunoglobulin G4-related disease (IgG4-RD) is a condition that was first reported as a type of autoimmune pancreatitis in 2001. It has gradually been recognized as a chronic fibroinflammatory condition with multiorgan involvement through such manifestations as sialadenitis, thyroiditis, nephritis, lymphadenopathy, and lung disease. Most reported cases of IgG4-RD with cardiovascular involvement have included abdominal aortic disease, with coronary artery disease (CAD) being rare. Here, we present a case of IgG4-RD involving CAD.

Timeline

Case presentation

A 74-year-old man with a history of CAD, cerebral infarction, and dyslipidaemia was referred to our hospital with a chief complaint of chest pain and was admitted. The patient had smoked 20 cigarettes per day for 53 years but had stopped smoking 1 year earlier. Physical examination had no significant findings and showed a blood pressure of 154/90 mmHg, a heart rate of 110 b.p.m., and a body temperature of 36.5°C. Electrocardiography showed ST-segment elevation in precordial leads and a depression in inferior leads (Figure ). Laboratory examinations showed elevated troponin levels, with a troponin T level of 0.458 ng/mL. Transthoracic echocardiography revealed impaired left ventricular wall motion in the anteroseptal area, with a left ventricular ejection fraction of 40–45%. A myocardial infarction with ST-segment elevation was diagnosed, and an urgent coronary angiogram revealed thrombotic occlusion of the proximal left anterior descending artery (LAD) (Supplementary material online, Files). There was no significant CAD in the left circumflex artery and right coronary artery (RCA). The antiplatelet regime the patient was commenced on at the time of coronary intervention included oral aspirin, 200 mg, and prasugrel, 20 mg. A 12-lead electrocardiogram on admission. ST-segment elevation in precordial leads and a depression in inferior leads. The patient underwent percutaneous coronary intervention with the implantation of a drug-eluting stent in the LAD (Supplementary material online, Files). Importantly, during the present admission of this patient for chest pain, the blood glucose level was high, with a fasting blood glucose level of 362 mg/dL (normal value: 73–109 mg/dL) and haemoglobin A1c level of 10.8% (normal value: 4.9–6.0%). Because, we were told by the patient’s previous physician that 6 months earlier the fasting blood glucose level had been 85 mg/dL and the haemoglobin A1c level had been 7.1%, abdominal contrast-enhanced computed tomography (CT) was performed to examine the pancreas. This examination showed diffuse enlargement and a surrounding capsule-like structure. On the basis of these findings, the differential diagnosis included autoimmune pancreatitis. In addition, because autoimmune pancreatitis is a typical finding of IgG4-RD,, the serum IgG4 level was examined and found to be extremely high (453 mg/dL; normal value: 4.8–105 mg/dL). Therefore, IgG4-RD was diagnosed, despite tissue biopsy not being performed. Intravascular ultrasonography of the coronary arteries demonstrated mild stenosis of the vascular lumen with an attenuated plaque and the thickening of adventitia in the proximal LAD branch (Figure ). Intravascular ultrasound. Mild stenosis of the vascular lumen with attenuated plaque (A). Thickening of adventitia in the proximal left anterior descending artery branch (B). To examine the radiological characteristics of the coronary arteries, coronary computed tomography angiography (CCTA) was performed. A heterogeneous slight thickening was found of coronary artery walls and surrounding soft tissue from the left main trunk through the proximal LAD branch and the proximal RCA. A localized nodular lesion was also observed in the middle of the RCA (Figure ). Coronary angiography also showed mild stenosis of the proximal LAD branch and the proximal RCA and localized mild stenosis in the middle of the RCA (Supplementary material online, Files). Coronary computed tomography angiography. Heterogeneous thickening of coronary artery wall and surrounding soft tissue in left anterior descending branch (A) and the right coronary artery (B). Localized nodular lesion in middle of right coronary artery (C). To investigate the involvement of other organs in IgG4-RD, gallium scintigraphy was performed. However, gallium accumulation was shown in only part of the pancreas. Contrast-enhanced CT showed only slight thickening of the walls of the thoracic and abdominal aorta, which could not be differentiated from atherosclerotic changes. With insulin therapy, the blood glucose level was significantly improved. The patient was discharged after 18 days without any complications of CAD. Upon discharge, the patient has closely been followed-up until the present time. The coronary angiogram 9 months after percutaneous coronary intervention did not reveal any restenosis or new lesion. In addition, CCTA performed at the time of coronary angiogram revealed slight wall thickening from the left main trunk through the proximal LAD branch and the proximal RCA. Significant thickening of soft tissue and a coronary aneurysm were not present. There were no remarkable changes compared with the findings of CCTA at the initial presentation. The medications prescribed on discharge included aspirin, 100 mg once daily; prasugrel, 3.75 mg once daily; rosuvastatin, 5 mg once daily; enalapril, 2.5 mg once daily; bisoprolol, 0.625 mg once daily; insulin glargine, once daily; and insulin lispro, three times a day.

Discussion

After IgG4-RD was first reported, many additional sites have been found, because of high serum levels of IgG4, to be involved. However, little evidence has been reported of the relationship between IgG4-RD and CAD. Therefore, to study the characteristics of CAD in IgG4-RD, we searched the literature and found 15 previously reported cases (Table 1).
Table 1

Characteristics of coronary artery disease in reported cases of immunoglobulin-G4–related disease

Reported caseYearPatient age, yearsSexLesion form of coronary artery
ACSImaging examinations
Wall thickeningSoft tissue thickeningStenosisAneurysm
Nishimura et al.4201660MnonoyesyesnoCCTA, CAG, TTE
Tanigawa et al.5201266MyesyesyesnoyesCCTA, CAG
Matsumoto et al.7200863FyesyesnoyesnoCCTA, CAG
Ikutomi et al.8201175MyesyesyesyesnoCCTA, CAG
Tajima et al.9201468MunknownyesnononoPET-CT, CCTA
Inokuchi et al.10201438Myesyesyesnoyes (CPA)CT
Urabe et al.11201284MyesyesyesyesyesCCTA, CAG
Patel et al.12201453Myesyesyesnoyes (CPA)autopsy
Guo et al.13201588MunknownyesunknownnonoCT
Takei et al.14201271MyesyesyesyesnoTTE, CCTA
Keraliya et al.15201653MyesyesyesyesyesCCTA, CAG
Sakamoto et al.16201767MunknownyesyesnonoCCTA, CAG
Komiya et al.17201859MunknownyesnononoTTE, CCTA, PET-CT
Bito et al.6201469MunknownnonoyesyesCAG, CCTA
Kan-o et al.18201568MyesnoyesyesnoCT, CCTA
Present Case201874MyesnoyesnoyesCAG, CCTA
TotalMean = 66M:F = 15:110 (63%)12 (75%)11 (69%)8 (50%)7 (44%)

ACS, acute coronary syndrome; CAG, coronary angiography; CCTA, coronary computed-tomography angiography; chest CT, computed tomography of chest; CPA, cardiopulmonary arrest; PET-CT, positron emission tomography–computed tomography; TTE, transthoracic echocardiography.

Characteristics of coronary artery disease in reported cases of immunoglobulin-G4–related disease ACS, acute coronary syndrome; CAG, coronary angiography; CCTA, coronary computed-tomography angiography; chest CT, computed tomography of chest; CPA, cardiopulmonary arrest; PET-CT, positron emission tomography–computed tomography; TTE, transthoracic echocardiography. Among these reported cases, the number of male patients was much higher than that of female patients, with a ratio of 15:1. The reason for male predominance with CAD in IgG4-RD remains uncertain, and the selection bias and an underdiagnosis in female patients could not be excluded. However, in the study by Komiya et al. of 10 cases of CAD in IgG4-RD, a high male:female predominance was shown with a ratio of 9:1, which was consistent with our finding. Contrary to the female predominance of general autoimmune conditions, patients with IgG4-RD would more likely be older men, and patients with CAD would also more likely be men. These factors might contribute to the male predominance of IgG4-RD, although more cases and further investigation are required. In the present case, thickening of coronary artery walls and of soft tissue surrounding several arteries was observed. Because such thickening has also been observed in 13 of 15 previously reported cases (Table 1), it might be a characteristic of CAD in IgG4-RD. Another possible characteristic of CAD in IgG4-RD is mild stenosis of the vascular lumen, which was found in the present case and in five of six previous cases with acute coronary syndrome (ACS) (Table 1). Cardiac involvement has been reported in cases of IgG4-RD; however, in light of the 15 previously reported cases, ACS is rarely concomitant with IgG4-RD. Instead, the type of cardiovascular involvement most often reported with IgG4-RD has been aortic disease. Interestingly, the features of thickening of coronary artery walls and surrounding soft tissue and of giant coronary artery aneurysm and aortic disease have also been shown in cases of CAD. Furthermore, a pathological perspective suggests that the periarterial thickening and luminal narrowing of the coronary arteries might lead to myocardial ischaemia. These pathological findings appear to be consistent with the present case; however, how the coronary lesion with periarterial thickening and luminal narrowing led to unstable CAD must be clarified. All three previously reported cases of ACS without aneurysm,, showed significant stenosis of the vascular lumen; however, the present case showed only mild stenosis. To the best of our knowledge, the present case is the first of ACS in IgG4-RD without an aneurysm or significant stenosis of the vascular lumen. The present case of IgG4-RD involving CAD was not diagnosed on the basis of tissue biopsy, which is a useful tool for diagnosing IgG4-RD, but on CT findings of heterogeneous thickening of coronary artery walls and concomitant autoimmune pancreatitis, in addition to an elevated serum level of IgG4. Previously reported cases were diagnosed with the following methods (Table 1): eight cases, pathological examination during operative therapy, including coronary artery bypass graft, or autopsy; six cases, CCTA or coronary angiographic findings depicting coronary artery lesions after IgG4-RD was diagnosed in other organs; and one case, findings of positron emission tomography CT. These data suggest that CCTA provides useful images for a diagnostic workup, because pathological findings are hard to obtain and cases of IgG4-RD involving CAD can be difficult to diagnose. With respect to treatment options, a corticosteroid was not administered at this stage of the present case for the following reasons. First, this case of CAD was not associated with findings characteristic of a significant mass, which would respond well to a corticosteroid.,, Second, this case had no symptoms, such as jaundice, due to autoimmune pancreatitis. Third, this case was concomitant with severe diabetes. Therefore, careful clinical follow-up should be performed, and corticosteroid therapy might be a reasonable option if coronary lesions progress at a later stage, because this case is most likely due to wall thickening without coronary aneurysm. The present report suggests that CAD, specifically ACS, can coexist with IgG4-RD. Notably, it is important to clarify that ACS cannot be definitively and directly attributed to IgG4-RD. Therefore, cases of the combination of CAD and IgG4-RD should be accurately diagnosed and evidence should be collected to elucidate the mechanism and characteristics of this condition. Click here for additional data file.
6 months before admissionNo evidence of severe impaired glucose tolerance; blood glucose was 85 mg/dL, and HbA1c was 7.1%.
2 months before admissionTightness of the chest on exertion
Day of admissionUpon admission, ST-segment elevation myocardial infarction diagnosed and urgent percutaneous coronary intervention performed. Markedly exacerbation of diabetes: blood glucose level, 362 mg/dL and HbA1c, 10.8%.
Hospital Day 3IgG4-RD diagnosed because of autoimmune pancreatitis and a high serum IgG4 level, 453 mg/dL.
Hospital Day 14Coronary computed tomography angiography revealed localized wall thickening of coronary artery.
Hospital Day 18Patient discharged.
9 months after dischargeCoronary angiography did not reveal any restenosis in the stent or any new lesions.
Coronary computed tomography angiography found no remarkable changes compared with the findings on primary admission.
19 months after dischargeThe follow-up serum IgG4 level had decreased to 330 mg/dL.
20 months after dischargeThe diabetes is well controlled with an HbA1c of 7.0% through the administration of insulin.
IgG4-RD has spontaneously been recovered without any treatment that includes corticosteroids.
  19 in total

1.  Immunoglobulin G4-related coronary periarteritis in a patient presenting with myocardial ischemia.

Authors:  Jun Tanigawa; Masahiro Daimon; Motonobu Murai; Takahiro Katsumata; Motomu Tsuji; Nobukazu Ishizaka
Journal:  Hum Pathol       Date:  2012-03-07       Impact factor: 3.466

Review 2.  IgG4-related disease.

Authors:  John H Stone; Yoh Zen; Vikram Deshpande
Journal:  N Engl J Med       Date:  2012-02-09       Impact factor: 91.245

3.  Pigs-in-a-blanket coronary arteries: a case of immunoglobulin G4-related coronary periarteritis assessed by computed tomography coronary angiography, intravascular ultrasound, and positron emission tomography.

Authors:  Yoji Urabe; Takashi Fujii; Shuji Kurushima; Shuji Tsujiyama; Yasuki Kihara
Journal:  Circ Cardiovasc Imaging       Date:  2012-09-01       Impact factor: 7.792

4.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

5.  A suspected case of coronary periarteritis due to IgG4-related disease as a cause of ischemic heart disease.

Authors:  Go Inokuchi; Mutsumi Hayakawa; Takashi Kishimoto; Yohsuke Makino; Hirotaro Iwase
Journal:  Forensic Sci Med Pathol       Date:  2013-12-12       Impact factor: 2.007

6.  A case of multiple giant coronary aneurysms and abdominal aortic aneurysm coexisting with IgG4-related disease.

Authors:  Hirofumi Takei; Hayato Nagasawa; Ryota Sakai; Koji Nishimura; Takahiko Kurasawa; Ayumi Okuyama; Eiko Nishi; Yuichiro Shirai; Tsuneo Kondo; Hiroe Ogawa; Tatsuya Ito; Koichi Amano
Journal:  Intern Med       Date:  2012-04-15       Impact factor: 1.271

7.  Giant tumorous lesions (correction of legions) surrounding the right coronary artery associated with immunoglobulin-G4-related systemic disease.

Authors:  Masayasu Ikutomi; Takayoshi Matsumura; Hiroshi Iwata; Go Nishimura; Nobukazu Ishizaka; Yasunobu Hirata; Minoru Ono; Ryozo Nagai
Journal:  Cardiology       Date:  2011-11-16       Impact factor: 1.869

8.  A case of multiple immunoglobulin G4-related periarteritis: a tumorous lesion of the coronary artery and abdominal aortic aneurysm.

Authors:  Yasushi Matsumoto; Satomi Kasashima; Atsuhiro Kawashima; Hisao Sasaki; Masamitsu Endo; Kengo Kawakami; Yoh Zen; Yasuni Nakanuma
Journal:  Hum Pathol       Date:  2008-04-21       Impact factor: 3.466

9.  Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis.

Authors:  Satomi Kasashima; Yoh Zen; Atsuhiro Kawashima; Keiko Konishi; Hisao Sasaki; Masamitsu Endo; Yasushi Matsumoto; Kengo Kawakami; Fuminori Kasashima; Makio Moriya; Keiichi Kimura; Hiroshi Ohtake; Yasuni Nakanuma
Journal:  Am J Surg Pathol       Date:  2008-02       Impact factor: 6.394

10.  Immunoglobulin G4-related multiple systemic aneurysms and splenic aneurysm rupture during steroid therapy.

Authors:  Miyu Tajima; Yukio Hiroi; Yutaka Takazawa; Hironori Muraoka; Hiroshi Iwata; Hiroshi Yamashita; Yasunobu Hirata; Ryozo Nagai
Journal:  Hum Pathol       Date:  2013-10-15       Impact factor: 3.466

View more
  6 in total

1.  Immunoglobulin G4-related inflammatory pseudotumor of the right ventricle with right coronary artery occlusion.

Authors:  Ikuko Shibasaki; Takahiro Nakajima; Taiki Matsuoka; Yasuyuki Kanno; Yuta Kanazawa; Yusuke Takei; Go Tuchiya; Shunsuke Saito; Taisuke Konishi; Masashi Sakuma; Shigeru Toyoda; Hirotsugu Fukuda
Journal:  J Cardiol Cases       Date:  2022-06-24

2.  Coil embolization to giant left anterior descending artery and left circumflex artery coronary artery aneurysm after failed coronary aneurysmal repair in IgG4-related disease: a case report.

Authors:  Panupong Pota; Pannipa Suwannasom; Surin Woragidpoonpol; Tanop Srisuwan
Journal:  Eur Heart J Case Rep       Date:  2021-11-08

3.  Intracoronary IgG4-related disease as an unusual cause of sudden cardiac arrest: a case series.

Authors:  Elizabeth D Paratz; Laura Ross; Dominica Zentner; Natalie Morgan; Heinrich Bouwer; Matthew Lynch; Sarah Parsons; Andre La Gerche
Journal:  Eur Heart J Case Rep       Date:  2022-02-03

4.  Immunoglobulin G4-related masses surrounding coronary arteries: a case report.

Authors:  Takuya Nakamura; Yutaka Goryo; Takuya Isojima; Hiroyuki Kawata
Journal:  Eur Heart J Case Rep       Date:  2021-03-08

Review 5.  Coronary Vasculitis.

Authors:  Tommaso Gori
Journal:  Biomedicines       Date:  2021-05-31

6.  Improvement of Mass Lesions around Coronary Arteries and Fractional Flow Reserve after Steroid Therapy in Immunoglobulin-G4-related Coronary Periarteritis.

Authors:  Naoki Kubota; Kazuyuki Ozaki; Makoto Hoyano; Takeshi Okubo; Shinpei Kimura; Takao Yanagawa; Takeshi Kashimura; Takayuki Inomata
Journal:  Intern Med       Date:  2022-02-01       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.